MedTrace Logo

TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse Oximeters

NCT05527990 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2023-10-26

No results posted yet for this study

Summary

This study aims to provide evidence on next-generation clinical measurement tools through a mixed methods diagnostic accuracy and implementation study in Kenya, Senegal, Tanzania, and Uttar Pradesh, India.

Conditions

  • Focus of Study: Accurate Clinical Measurement and Diagnosis

Interventions

DEVICE

Multimodal PO

Mixed methods diagnostic accuracy and implementation of multimodal PO

Sponsors & Collaborators

  • UNITAID

    collaborator OTHER

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • PATH

    lead OTHER

Eligibility

Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-20
Primary Completion
2023-12-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05527990 on ClinicalTrials.gov